The stock of Indivior PLC (LON:INDV) reached all time high today, Nov, 4 and still has GBX 545.28 target or 53.00% above today’s GBX 356.39 share price. This indicates more upside for the GBX 2.56 billion company. This technical setup was reported by Barchart.com. If the GBX 545.28 PT is reached, the company will be worth GBX 1.36B more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. The stock decreased 3.42% or GBX 12.61 on November 4, hitting GBX 356.39. About 3.09 million shares traded hands or 26.12% up from the average. Indivior PLC (LON:INDV) has risen 109.63% since April 7, 2016 and is uptrending. It has outperformed by 108.54% the S&P500.
Indivior PLC (LON:INDV) Ratings Coverage
Out of 8 analysts covering Indivior Plc (LON:INDV), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. Indivior Plc has been the topic of 69 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Deutsche Bank maintained it with “Buy” rating and GBX 400 target price in Thursday, November 3 report. The firm earned “Buy” rating on Monday, October 26 by Deutsche Bank. The rating was maintained by Deutsche Bank on Friday, February 19 with “Buy”. On Wednesday, June 8 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Buy” rating on Tuesday, November 3 by Jefferies. As per Friday, November 6, the company rating was maintained by Jefferies. On Tuesday, October 4 the stock rating was maintained by Deutsche Bank with “Buy”. Jefferies maintained it with “Buy” rating and GBX 320 target price in Tuesday, July 26 report. Cantor Fitzgerald maintained Indivior PLC (LON:INDV) on Wednesday, August 17 with “Hold” rating. The rating was maintained by Deutsche Bank on Monday, March 7 with “Buy”.
More important recent Indivior PLC (LON:INDV) news were published by: Prnewswire.com which released: “Indivior PLC Announces Positive Top-line Results From Pivotal Phase 3 Trial of …” on May 05, 2015, also Fool.Co.Uk published article titled: “Will Indivior plc (+71%), Serco Group plc (+33%) & Indus Gas Limited (+105 …”, Fool.Co.Uk published: “Are GlaxoSmithKline plc and Indivior plc the perfect pharma pairing?” on May 31, 2016. More interesting news about Indivior PLC (LON:INDV) was released by: Fool.Co.Uk and their article: “Indivior PLC Scraps Dividend: Should You Sell And Buy AstraZeneca plc Or Shire …” with publication date: February 18, 2016.
Indivior PLC is a specialty pharmaceutical company. The company has a market cap of 2.56 billion GBP. The Firm is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. It currently has negative earnings. The Company’s treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.